189 related articles for article (PubMed ID: 2210078)
1. Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
Bougnères PF; Landais P; Boisson C; Carel JC; Frament N; Boitard C; Chaussain JL; Bach JF
Diabetes; 1990 Oct; 39(10):1264-72. PubMed ID: 2210078
[TBL] [Abstract][Full Text] [Related]
2. Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
Assan R; Feutren G; Sirmai J; Laborie C; Boitard C; Vexiau P; Du Rostu H; Rodier M; Figoni M; Vague P
Diabetes; 1990 Jul; 39(7):768-74. PubMed ID: 2191883
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
Assan R; Feutren G; Debray-Sachs M; Quiniou-Debrie MC; Laborie C; Thomas G; Chatenoud L; Bach JF
Lancet; 1985 Jan; 1(8420):67-71. PubMed ID: 2857024
[TBL] [Abstract][Full Text] [Related]
5. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials of cyclosporin in IDDM.
Dupré J; Stiller CR; Gent M; Donner A; von Graffenried B; Heinrichs D; Jenner M; Keown P; Mahon J; Martell R
Diabetes Care; 1988; 11 Suppl 1():37-44. PubMed ID: 3069390
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of early cyclosporin therapy in juvenile IDDM.
De Filippo G; Carel JC; Boitard C; Bougnères PF
Diabetes; 1996 Jan; 45(1):101-4. PubMed ID: 8522052
[TBL] [Abstract][Full Text] [Related]
9. Natural course of remission in IDDM during 1st yr after diagnosis.
Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
[TBL] [Abstract][Full Text] [Related]
10. Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus.
Snorgaard O; Hartling SG; Binder C
Diabetologia; 1990 Jan; 33(1):36-42. PubMed ID: 2303172
[TBL] [Abstract][Full Text] [Related]
11. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.
Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T
Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302
[TBL] [Abstract][Full Text] [Related]
12. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics.
Mandrup-Poulsen T; Nerup J; Stiller CR; Marner B; Bille G; Heinrichs D; Martell R; Dupre J; Keown PA; Jenner MR
Lancet; 1985 Mar; 1(8429):599-602. PubMed ID: 2857945
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
Stiller CR; Dupré J; Gent M; Jenner MR; Keown PA; Laupacis A; Martell R; Rodger NW; von Graffenried B; Wolfe BM
Science; 1984 Mar; 223(4643):1362-7. PubMed ID: 6367043
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of insulin release in vitro mediated by mononuclear cells from diabetic patients treated with cyclosporin A or placebo.
Debray-Sachs M; Sai P; Feutren G; Lang F; Maugendre D; Boitard C; Hors J; Bach JF
Diabetes; 1988 Jul; 37(7):873-7. PubMed ID: 3290005
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
[TBL] [Abstract][Full Text] [Related]
16. Seven years of remission in a type I diabetic patient.
Koivisto VA; Leirisalo-Repo M; Ebeling P; Tuominen JA; Knip M; Turunen U; Mandrup-Poulsen T; Pelkonen R
Diabetes Care; 1993 Jul; 16(7):990-5. PubMed ID: 8359107
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
[TBL] [Abstract][Full Text] [Related]
18. [Use of cyclosporin A for remission induction in newly-detected insulin-dependent diabetes].
Zamaklar M; Lalić N; Djordjević P; Dragasević M; Vujosević S; Savić K; Kalimanovska V
Glas Srp Akad Nauka Med; 1994; (44):89-100. PubMed ID: 7590419
[TBL] [Abstract][Full Text] [Related]
19. [Insulin/glucagon relationship in spontaneous diabetic remission].
Cresto JC; Sires JM; Ramos O; Abdenur JE; Basabe JC
Medicina (B Aires); 1991; 51(3):195-203. PubMed ID: 1821901
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
